FDA staffers in the Center for Devices and Radiological Health told NBC News that their AI pilot, CDRH-GPT, is buggy, isn't ...

Dubbed Elsa, the tool was expected to roll out at the end of June. The FDA says it marks the dawn of a new era.

The FDA plans to "unleash AI" on new drug evaluations in order to "radically increase efficiency in the review process." ...

Tonight’s the premiere of Dimension 20’s steampunk-themed Cloudward, Ho! series. I’m excited; anyone else? (If you’re ...

The agency has provided few details about its AI pilot as it makes moves on its “aggressive timeline” for rollout.

The FDA launched Elsa, its first generative AI tool, to streamline reviews and modernize agency workflow across all centers.

The Food and Drug Administration has officially launched "Elsa," a generative artificial intelligence platform designed to ...

Learn more about the generative AI technology that will be used at the Food and Drug Administration (FDA) to speed up reviews ...

The U.S. FDA announced this week that it deployed a generative AI tool called ELSA, now in use by staff across the agency, ...

The agency has provided only limited details about its AI pilot as it advances an “aggressive timeline” for the tool's ...